Front Row Advisors’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-13,078
Closed -$958K 1094
2019
Q1
$958K Buy
13,078
+35
+0.3% +$2.53K 0.75% 46
2018
Q4
$879K Buy
13,043
+220
+2% +$15.5K 0.76% 45
2018
Q3
$864 Buy
12,823
+200
+2% +$16K 0.61% 52
2018
Q2
$980 Buy
12,623
+725
+6% +$54.3K 0.63% 49
2018
Q1
$747K Buy
11,898
+925
+8% +$61.6K 0.52% 58
2017
Q4
$695K Buy
+10,973
New +$782K 0.55% 56

Other funds holding MDSO

Front Row Advisors's MDSO Position: Q2 2019 in Review

Front Row Advisors sold out of Medidata Solutions, Inc. (MDSO) in Q2 2019, closing a stake of 13,078 shares — an estimated $958K sold.

Front Row Advisors first reported a position in MDSO in Q4 2017 and held it in 6 quarters. The position peaked at $958K in Q1 2019. 302 funds tracked by Wall St. Rank hold MDSO as of Q2 2019.

  • Front Row Advisors reported no remaining Medidata Solutions, Inc. position as of Q2 2019 after selling out during the quarter.
  • Front Row Advisors sold 13,078 Medidata Solutions, Inc. shares in Q2 2019, an estimated $958K.
  • Front Row Advisors first reported a position in Medidata Solutions, Inc. in Q4 2017 and held it in 6 quarters.
  • Front Row Advisors's Medidata Solutions, Inc. position peaked at $958K in Q1 2019.
  • 302 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q2 2019.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.